RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,349 | -16.3% | 27,175 | 0.0% | 0.00% | – |
| Q2 2023 | $35,056 | -2.3% | 27,175 | 0.0% | 0.00% | – |
| Q1 2023 | $35,871 | -12.0% | 27,175 | 0.0% | 0.00% | – |
| Q4 2022 | $40,763 | +23.5% | 27,175 | -4.0% | 0.00% | – |
| Q3 2022 | $33,000 | -19.5% | 28,305 | -21.3% | 0.00% | – |
| Q2 2022 | $41,000 | -62.0% | 35,988 | 0.0% | 0.00% | – |
| Q1 2022 | $108,000 | +13.7% | 35,988 | 0.0% | 0.00% | – |
| Q4 2021 | $95,000 | +2.2% | 35,988 | +40.8% | 0.00% | – |
| Q3 2021 | $93,000 | +32.9% | 25,568 | +58.9% | 0.00% | – |
| Q2 2021 | $70,000 | +180.0% | 16,088 | +39.9% | 0.00% | – |
| Q4 2019 | $25,000 | +13.6% | 11,500 | 0.0% | 0.00% | – |
| Q3 2019 | $22,000 | -26.7% | 11,500 | 0.0% | 0.00% | – |
| Q2 2019 | $30,000 | -14.3% | 11,500 | -14.8% | 0.00% | – |
| Q1 2019 | $35,000 | +12.9% | 13,500 | 0.0% | 0.00% | – |
| Q4 2018 | $31,000 | -16.2% | 13,500 | +17.4% | 0.00% | – |
| Q3 2018 | $37,000 | +12.1% | 11,500 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |